Lineage Cell Therapeutics, Inc. (LCTX)
1.364
-0.07
(-4.62%)
USD |
NYAM |
May 07, 16:00
1.37
+0.01
(+0.44%)
After-Hours: 20:00
Lineage Cell Therapeutics EPS Diluted (Quarterly) : 0.0035 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0758 |
| Pacira Biosciences, Inc. | 0.0713 |
| Niagen Bioscience, Inc. | 0.0489 |
| Strata Critical Medical, Inc. | 0.0277 |
| Prime Medicine, Inc. | -0.2553 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.892M |
| Revenue (Quarterly) | 6.608M |
| Total Expenses (Quarterly) | 5.757M |
| Enterprise Value | 301.63M |
| Gross Profit Margin (Quarterly) | 96.19% |
| Profit Margin (Quarterly) | 13.50% |
| Earnings Yield | -20.40% |
| Normalized Earnings Yield | -9.040 |